Risikoen for at overføre attenueret vaccinevirus til modtagelige individer skal ses i forhold til risikoen for at udvikle naturlig infektion med herpes zoster, som kan spredes til disse individer.
The risk of transmitting the attenuated vaccine virus to a susceptible individual should be weighed against the risk of developing natural herpes zoster that could be transmitted to a susceptible individual.